Quarterly Focus Issue: Heart FailureClinical ResearchQuantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction: A Meta-Analytic Approach
Clinical Research
Under an Elsevier user license
open archive
Key Words
heart failure
remodeling
clinical trials
Abbreviations and Acronyms
AUC
area under the curve
CI
confidence interval
EDV
end-diastolic volume
ESV
end-systolic volume
HF
heart failure
IQR
interquartile range
LVD
left ventricular dysfunction
LVEF
left ventricular ejection fraction
NYHA
New York Heart Association
OR
odds ratio
RCT
randomized controlled trial
ROC
receiver-operating characteristic
Cited by (0)
This article was partially funded by the grant NIH/NCRR UL1RR025752, Tufts Clinical and Translational Science Institute. Dr. Konstam is a consultant for Boehringer-Ingelheim, Trevena, Johnson & Johnson, Cardioxyl, Merck, and Forest. Dr. Udelson is a consultant for Cytori, Angioblast, and Medtronic.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.